The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design

Abstract Background Many screening programs for colorectal cancer (CRC) use the fecal immunochemical test (FIT) to triage individuals for colonoscopy. Although these programs reduce CRC incidence and CRC-related mortality, the detection of advanced precursor lesions (advanced adenomas and advanced s...

Full description

Bibliographic Details
Main Authors: P. H. A. Wisse, W. de Klaver, F. van Wifferen, L. Meiqari, M. Bierkens, M. J. E. Greuter, B. Carvalho, M. E. van Leerdam, M. C. W. Spaander, E. Dekker, V. M. H. Coupé, M. de Wit, G. A. Meijer
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Cancer
Subjects:
Fecal immunochemical test
Multitarget fecal immunochemical test
Screening
Advanced neoplasia
Colorectal cancer
Health economic modelling
Online Access:https://doi.org/10.1186/s12885-022-10372-2

Internet

https://doi.org/10.1186/s12885-022-10372-2

Similar Items